8BT5 image
Entry Detail
PDB ID:
8BT5
Keywords:
Title:
Notum Inhibitor ARUK3004877
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-11-27
Release Date:
2022-12-14
Method Details:
Experimental Method:
Resolution:
1.40 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Palmitoleoyl-protein carboxylesterase NOTUM
Chain IDs:A
Chain Length:383
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity.
Eur.J.Med.Chem. 251 115132 115132 (2023)
PMID: 36934521 DOI: 10.1016/j.ejmech.2023.115132

Abstact

N-Acyl indolines 4 are potent, non-covalent Notum inhibitors developed from a covalent virtual screening hit 2a. The lead compounds were simple to synthesise, achieved excellent potency in a biochemical Notum-OPTS assay and restored Wnt signalling in a cell-based TCF/LEF reporter assay. Multiple high resolution X-ray structures established a common binding mode of these inhibitors with the indoline bound centred in the palmiteolate pocket with key interactions being aromatic stacking and a water mediated hydrogen bond to the oxyanion hole. These N-acyl indolines 4 will be useful tools for use in vitro studies to investigate the role of Notum in disease models, especially when paired with a structurally related covalent inhibitor (e.g. 4w and 2a). Overall, this study highlights the designed switch from covalent to non-covalent Notum inhibitors and so illustrates a complementary approach for hit generation and target inhibition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures